1 Result

People

  1. Benayed
    Benayed
  2. Berger
    Berger
  3. Drilon
    Drilon
  4. Hanusch
    Hanusch
  5. Hechtman
    Hechtman
  6. Hyman
    Hyman
  7. Jonsson
    Jonsson
  8. Raj
    Raj
  9. Scaltriti
    Scaltriti
  10. Schram
    Schram

Groups

  1. Department of Medicine (1)
  2. Early Drug Development Service (1)
  3. GME, Medicine (1)
  4. GSK Faculty (1)
  5. Graduate Medical Education (1)
  6. Gynecologic Medicine Service (1)
  7. Hematology-Oncology Fellows (1)
  8. Human Oncology and Pathogenesis Program (1)
  9. Sloan Kettering Institute Postdocs (1)
  10. Solid Tumor Oncology Division (1)
  1. "2017"
  2. "Solid Tumor Oncology Division"
  3. "Alexander Drilon"
  4. "Graduate Medical Education"
Formats
  1. Journal Article (1)
Groups
  1. Department of Medicine (1)
  2. Early Drug Development Service (1)
  3. GME, Medicine (1)
  4. GSK Faculty (1)
  5. Graduate Medical Education (1)
  6. Gynecologic Medicine Service (1)

More Groups

People
  1. Alexander Drilon (1)
  2. Alison Schram (1)
  3. Barry Taylor (1)
  4. Bethany Hanusch (1)
  5. David Hyman (1)
  6. Jaclyn Hechtman (1)

More People

Years
  1. 2017 (1)
Publications
  1. Cancer Discovery (1)
Publishers
  1. American Association for Cancer Research (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors
    Journal Article

    Drilon, A.; Nagasubramanian, R.; Blake, J. F.; Ku, N.; Tuch, B. B.; Ebata, K.; Smith, S.; Lauriault, V.; Kolakowski, G. R.; Brandhuber, B. J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save